Z-0937-2021 Class II Terminated
Recall Details
- Product Type
- Devices
- Report Date
- February 3, 2021
- Initiation Date
- December 11, 2020
- Termination Date
- April 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 575 kits US
Product Description
therascreen PIK3CA RGQ PCR Kit (23) US IVD product- aid clinicians in identifying breast cancer patients who may be eligible for treatment with PIQRAY (alpelisib) based on a PIK3CA Mutation Detected result. REF 873121
Reason for Recall
Kit may generate false Q546R mutation positive results caused by nonspecific molecular interactions within the Q546R higher than previously observed and described within the Instructions For Use.
Distribution Pattern
CA, IN, MI, MN, NC, NJ, NM, OH, TX
Code Information
All lots